Subscribe To
STVN / Stevanato Group S.p.A. (STVN) CEO Franco Moro on Q4 2021 Results - Earnings Call Transcript
STVN News
By Seeking Alpha
October 31, 2023
Stevanato Group S.p.A. (STVN) Q3 2023 Earnings Call Transcript
Stevanato Group S.p.A. (STVN) Q3 2023 Earnings Call Transcript more_horizontal
By Zacks Investment Research
October 27, 2023
TAK vs. STVN: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Takeda Pharmaceutical Co. (TAK) and Stevanato Group (STV more_horizontal
By Zacks Investment Research
October 11, 2023
USNA or STVN: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences (USNA) or Stevanato Group (STVN). But w more_horizontal
By Seeking Alpha
September 15, 2023
Stevanato: Secular Tailwinds In Biologics Support Downstream Demand
Stevanato Group is a global provider of drug containment with a CAPEX growth plan to support growth and reach new geographical diversification. Balanc more_horizontal
By Zacks Investment Research
September 11, 2023
All You Need to Know About Stevanato (STVN) Rating Upgrade to Buy
Stevanato (STVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the more_horizontal
By Zacks Investment Research
June 19, 2023
Strength Seen in Stevanato (STVN): Can Its 5.0% Jump Turn into More Strength?
Stevanato (STVN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help th more_horizontal
By Seeking Alpha
June 14, 2023
Stevanato Group: Undeniable Quality, But Lacking Upside
Stevenato Group is a Pharmaceutical Manufacturing leader, generating 15% net income margins annually. The company has developed a global customer base more_horizontal
By Business Wire
May 24, 2023
Stevanato Group to Present at Upcoming Investor Conferences
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnost more_horizontal